COVID-19 positive patient operated on for an insulinoma

Authors

Keywords:

insulinoma, neuroendocrine, COVID-19.

Abstract

Introduction: Insulinoma is a neuroendocrine neoplasm considered one of the rarest, it arises in the beta cells of the islets of Langerhans, it produces insulin constantly, thus causing hypoglycemia. Its diagnosis is based on clinical, analytical and imaging criteria. Curative treatment is surgery, through enucleation of the tumor, partial or total pancreatectomy, or cephalic pancreaticoduodenectomy. The current pandemic gave rise to new action protocols, in order to adapt health resources without compromising the safety of patients and health personnel.
Objective: To present a clinical case of a patient diagnosed with insulinoma who required surgical treatment in the course of COVID-19.
Clinical case: 48-year-old female patient, with episodes of severe hypoglycemia and difficulty in proper clinical follow up. She was diagnosed with insulinoma and COVID-19, the latter worsened the patient's symptoms in such a way that adequate metabolic control was impossible. Surgical treatment was decided. The tumor was enucleated, without complications.
Conclusiones: Surgery is the definitive treatment to achieve cure in the case of neuroendocrine tumors, COVID-19 worsens the prognosis of patients with this tumor. Therefore, the decision of surgical treatment must be made in a multidisciplinary discussion in order to avoid postoperative complications.

Downloads

Download data is not yet available.

References

1. Suárez Rodríguez C, Collado Falcón JC. Características y tratamiento del paciente oncológico en el marco de la actual pandemia de la COVID-19. Revista Habanera de Ciencias Médicas. 2020 [acceso: 28/06/2021]; 19(Supl):e_3396 [aprox. 11 pant]. Disponible en: https://www.revhabanera.sld.cu/index.php/rhab/article/view/3396

2. Medina Zamora P, Lucio Figueroa JO. Insulinoma: revisión actual de manejo y tratamiento. Revista Médica MD. 2016 [acceso: 17/06/2021]; 7(2):83-90. Disponible en: https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=63611

3. Chapa Azuela Ó, Roca Vásquez C, Flores Rangel GA, Botello Hernández Z, Fuentes Reyes R. Insulinomas pancreáticos. Experiencia de seis años en la Clínica de Cirugía Hepatopancreatobiliar del Hospital General de México. Cirujano General. 2017 [acceso: 17/06/2021]; 39(3): 139-146. Disponible en: https://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S1405-00992017000300139&lng=es&nrm=iso

4. Chirinos Revilla JL, Fernández Sivincha JG. Insulinoma descubierto en paciente con aparente trastorno mental: reporte de un caso. Revista de Gastroenterología de Perú. 2018 [acceso: 17/06/2021]; 38(1): 82-4. Disponible en: https://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1022-51292018000100013

5. Vilchez MF, Ferreyra L. Manifestaciones neuropsiquiátricas en Insulinoma: presentación de un caso clínico. Experiencia Médica. 2008 [acceso: 04/06/2021]; 26(4): 122-6. Disponible en: https://xdoc.mx/documents/manifestaciones-neuropsiquiatricas-en-insulinoma-601b81b0df737

6. G. Díaz A. Insulinoma. Separata. 2012 [acceso: 17/06/2021]; 20(4): 1-24. Disponible en: https://www.montpellier.com.ar/Uploads/Separatas/Separata%2034%2-0Insulinoma.pdf

7. Bustamante Odriozola J, Pérez Martín A, Huarachi Berne N, Suárez Rodríguez AI, San Miguel Martín N, Martínez Revuelta D. Hipoglucemia en una paciente no diabética. Medicina General y de Familia. 2020 [acceso: 08/06/2021]; 9(1): 38-40. Disponible en: https://mgyf.org/hipoglucemia-en-una-paciente-no-diabetica/

8. Dosouto Infante V, Monteiro Soares MR, Lemus Dosouto Y, Flores Ramírez I, García Fajardo JD. Aspectos tomográficos e histológicos en pacientes con neoplasia exocrina de páncreas. MEDISAN. 2020 [acceso: 08/06/2021]; 24(4): 610-26. Disponible en: https://www.medisan.sld.cu/index.php/san/article/view/2866/html

9. Casey R, Valk G, Schalin-Jäntti C, Grossman A, Thakker R. Clinical management of neuroendocrine neoplasms (NENs). European Journal of Endocrinology. 2020 [acceso: 08/06/2021]; 183(2):79-88. Disponible en: https://covid19.elsevierpure.com/en/publications/clinical-management-of-neuroendocrine-neoplasms-nens

10. Maldonado Marcos E, Caula Freixa C, Planellas Giné P, Rodríguez Hermosa JI, López Ben S, Delisau Puig O, et al. Estudio del impacto de la pandemia por SARS-CoV-2 en la práctica quirúrgica urgente y electiva en un hospital de tercer nivel. Cirugía Española. 2021 [acceso: 17/06/2021]; 99(5):368-73. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402232/

11. Benalcázar Villacreses DE, González Eral Y, Rodríguez Álvarez M, Ojeda Delgado L. Manejo anestésico del Insulinoma. Presentación de un caso. Medisur. 2016 [acceso: 04/06/2021]; 14(4): 464-8. Disponible en: https://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1727-897X2016000400014&lng=es&nrm=iso&tlng=es

12. Pacheco M, Adriana Torres P, Arias F, Pinilla R, Abadía M, Villarreal R, et al. Recomendaciones para cirugía en pacientes con patologías oncológicas durante la pandemia COVID-19. Revista Colombiana de Cirugía. 2020 [acceso: 28/06/2021]; 35(2): 162-70. Disponible en: https://doi.org/10.30944/20117582.616

13. González López A, Parody Wadi A, Linares Marín S, Ortega Ávila JO. Insulinoma: bases clínicas para un enfoque adecuado en la práctica médica. Revisión de la literatura. Salutem Scientia Spiritus. 2021 [acceso: 04/06/2021]; 7(1): 86-93. Disponible en: https://revistas.javerianacali.edu.co/index.php/salutemscientiaspiritus-/article/download/2358/3040/

Downloads

Published

2021-12-30

How to Cite

1.
Licea Videaux M, Palacios Morejon IU, Zamora Santana O, Chacón Melcón RJ. COVID-19 positive patient operated on for an insulinoma. Rev Cubana Med Milit [Internet]. 2021 Dec. 30 [cited 2025 Apr. 2];51(1):e02201508. Available from: https://revmedmilitar.sld.cu/index.php/mil/article/view/1508

Issue

Vol. 51 No. 1 (2022): January - March

Section

Case Presentation

License

Authors who have publications with this Journal accept the following terms:

  • The authors will retain their copyright and guarantee the Journal the right of first publication of their work, which will simultaneously be subject to the Creative Commons Attribution License. The content presented here can be shared, copied and redistributed in any medium or format; Can be adapted, remixed, transformed or created from the material, using the following terms: Attribution (giving appropriate credit to the work, providing a link to the license, and indicating if changes have been made); non-commercial (you cannot use the material for commercial purposes) and share-alike (if you remix, transform or create new material from this work, you can distribute your contribution as long as you use the same license as the original work).
  • The authors may adopt other non-exclusive license agreements for the distribution of the published version of the work (for example: depositing it in an institutional electronic archive or publishing it in a monographic volume) as long as the initial publication in this Journal is indicated.
  • Authors are allowed and recommended to disseminate their work through the Internet (e.g., in institutional electronic archives or on their website) before and during the submission process, which can produce interesting exchanges and increase citations. of the published work.